Dr. Fadi M. Kayali, MD

  • Sarasota, FL
  • Medical oncologist
NPI1003031212PAC ID5890830624
Medicare services, 2024
217,744
Medicare patients, 2024
1,171
Part D claims, 2024
3,272
Publications
21
Clinical trials
10
Practice address
1700 S Tamiami Trl, Sarasota, FL 34239
Practice phone
Call (941) 917-9000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

See all 7 affiliations

Find Dr. Kayali's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Fadi M. Kayali is a medical oncologist in Sarasota, Florida

Dr. Kayali practices at Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System.

Dr. Kayali's NPI, 1003031212, was assigned on April 13, 2007. Dr. Kayali graduated from St Petersburg Medical State Academy in 1997. Dr. Kayali holds Florida license ME106289.

NPI and contact details
Medicare PAC ID
5890830624
NPI enumeration date
April 13, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(941) 917-9000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
55
Medical school graduation
1997

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Fadi M. Kayali practices at Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida

Dr. Kayali's primary practice is Sarasota Memorial Hospital - Sarasota Campus, at 1700 S Tamiami Trl, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 917-9000.

Source: Dmand AI Affiliation Data

Dr. Fadi M. Kayali is affiliated with 6 sites of care and 1 medical group

Dr. Kayali's primary practice is Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System. Dr. Kayali is also affiliated with Sarasota Memorial Hospital-Venice. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Kayali to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

See all 7 affiliations for Dr. Kayali

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Fadi M. Kayali's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kayali practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Sarasota Memorial Hospital - Sarasota CampusAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Kayali practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Sarasota Memorial Health Care System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Fadi M. Kayali is one of 477 medical oncologists in Florida

Medical oncology is Dr. Kayali's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kayali is board certified in hospice and palliative medicine by the American Board of Anesthesiology. Dmand AI has Dr. Kayali's licenses on file in 4 states: Florida, Oklahoma, Kentucky and Michigan.

Specialties and state licenses

  • Medical oncology, FloridaPrimaryLicense ME106289 · 2010 to 2026 · taxonomy 207RX0202X
  • Oklahoma license2011 to 2012
  • Kentucky license2007 to 2011
  • Internal medicine, MichiganLicense 4301083320 · 2004 to 2007 · taxonomy 207R00000X

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Kayali treats.

Medical oncologists near Dr. Kayali

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Fadi M. Kayali billed Medicare for 217,744 services in 2024

CMS data shows 217,744 Medicare services from Dr. Kayali across 51 procedure codes in 2024, for 1,171 Medicare patients. Medicare paid $2,099,187 for them. Every service was in an office.

Medicare services, 2024217,744
Medicare patients1,171
Paid by Medicare$2.1M
Procedure codes51

Dr. Kayali's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Other services
2023: 100,8562024: 128,57727%
Drugs given in the office
2023: 144,0222024: 75,40748%
Tests and treatments
2023: 4,9252024: 4,8991%
Lab and pathology
2023: 3,7362024: 3,4418%
Surgery
2023: 3,2682024: 2,9819%
Office and hospital visits
2023: 2,6622024: 2,4398%
Imaging
2023: 132024: 0100%

Dr. Kayali compared with the Florida median for medical oncologists, 2024

  • Dr. Kayali
  • Florida median
Medicare services
217,744vs 19,75511.0 times
Medicare patients
1,171vs 5412.2 times
Part D claims
2,794vs 5984.7 times

Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Kayali's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kayali

Need commercial claims for Dr. Kayali?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kayali and other medical oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Fadi M. Kayali treated 1,171 Medicare patients in 2024, average age 76

CMS counts 1,171 Medicare patients who saw Dr. Kayali in 2024. The largest group is 75 to 84, with 532 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kayali's median patient age at 67, with 64% women.

Medicare patients, 20241,171
Average age76
Average risk score1.94
Also on Medicaid7%

Dr. Kayali's Medicare patients by age, 2024

Dr. Kayali's Medicare patients by sex, 2024

  • Women65656%
  • Men51544%

Chronic conditions among Dr. Kayali's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis53%
  4. Ischemic heart disease41%
  5. Cancer38%
  6. Chronic kidney disease32%
  7. Anxiety29%
  8. Diabetes28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kayali's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women64%
  • Men34%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Fadi M. Kayali wrote 3,272 Medicare Part D claims in 2024

In 2024, Dr. Kayali wrote 3,272 Medicare Part D claims for 410 patients. 74% of them were for generic drugs. CMS names the drug for 2,794 of them, across 73 drugs with 11 or more claims each, at $4,689,415 in total drug cost. In 2023, CMS named 3,119 claims across 75 drugs.

Part D claims, 20243,272
Drugs named by CMS73
Total drug cost$4.7M
Part D patients410

Dr. Kayali's Part D claims by kind of drug, 2024

  • Generic2,431 claims74%
  • Brand-name and other841 claims26%

Dr. Kayali's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kayali's Part D claims, 2024

  • Opioids10%328 of 3,272 claims
  • Antibiotics5%152 of 3,272 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3,1192024: 2,79410%

Drugs named by CMS: 73 in 2024, 75 in 2023.

See all prescribing by Dr. Kayali

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Fadi M. Kayali scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kayali for performance year 2024, reported as part of a group. Dr. Kayali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kayali as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Kayali by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Fadi M. Kayali has 21 publications on record

Dmand AI links 21 papers to Dr. Kayali, published from 2005 to 2018. The most frequent topics are Pulmonary Embolism, Venous Thrombosis and Angiography. Dr. Kayali has published most often in Am J Cardiol. Dr. Kayali's most frequent co-authors are Issa G. Alesh, MD, Majd Alnas, MD and Javier A. Pinilla-Ibarz, MD.

Papers21
Years published2005 to 2018

Topics Dr. Kayali writes about most

  • Pulmonary Embolism
  • Venous Thrombosis
  • Angiography
  • Age Distribution
  • Black or African American
  • Data Collection
  • Predictive Value of Tests
  • Probability

Dr. Kayali's most frequent co-authors

Recent publications by Dr. Kayali

See all 21 publications and co-authors

See who Dr. Kayali researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kayali works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Fadi M. Kayali has worked on 10 clinical trials

Dmand AI links Dr. Kayali to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

Clinical trials with Dr. Kayali by phase

  1. NonePhase 1: no trials
  2. 4Phase 2: 4 trials
  3. 1Phase 2/3: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Trials with no phase (devices, behavioral studies) are left out.

Conditions in Dr. Kayali's trials

  • Adenocarcinoma of Lung
  • Biliary Atresia
  • Low Back Pain
  • Malocclusion
  • Muscular Atrophy

Investigators on the most trials with Dr. Kayali

Recent clinical trials with Dr. Kayali

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Fadi M. Kayali received $33,196 in industry payments from 2016 to 2025

CMS Open Payments shows 1,352 general payments to Dr. Kayali from 104 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Genentech, Inc. paid the most, $3,526.

General payments to Dr. Kayali by program year, 2016 to 2025

General payments to Dr. Kayali by kind, 2016 to 2025

$33.2Kin total
  • Food and beverage$26,90181%
  • Consulting fees$2,4287%
  • Speaker and faculty fees$2,0006%
  • Honoraria$9003%
  • Other$9683%

Companies that paid Dr. Kayali the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kayali

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Fadi M. Kayali has 1 award and honors on record

Dmand AI lists 1 award for Dr. Kayali, most recently CMS Stage 1 EHR in 2014.

Awards and honors for Dr. Kayali

  1. 2014
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Fadi M. Kayali graduated from St Petersburg Medical State Academy

Dr. Kayali graduated from St Petersburg Medical State Academy in 1997.

  1. Medical schoolSt Petersburg Medical State Academy
  2. Board certified in hospice and palliative medicineAmerican Board of Anesthesiology
  3. Board certified in hematologyAmerican Board of Internal Medicine
  4. Board certified in hospice and palliative medicineAmerican Board of Internal Medicine
  5. Board certified in internal medicineAmerican Board of Internal Medicine
  6. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Fadi M. Kayali accepts plans from 18 insurance carriers

Dr. Kayali is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Plan types Dr. Kayali accepts, by number of carriers

  1. PPO12
  2. Medicare11
  3. HMO10
  4. POS6
  5. EPO5

Source: Dmand AI Insurance Network Data

Sources for Dr. Fadi M. Kayali's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Fadi M. Kayali

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Fadi M. Kayali's NPI number?

Dr. Fadi M. Kayali's NPI number is 1003031212. It was assigned on April 13, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Fadi M. Kayali?

Dr. Fadi M. Kayali is a medical oncologist in Sarasota, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Fadi M. Kayali practice?

Dr. Kayali practices at 1700 S Tamiami Trl, Sarasota, FL 34239. Dr. Kayali's primary practice is Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System. Dmand AI also links Dr. Kayali to 2 hospitals, 1 group practice or clinic and 1 home health agency.

What is Dr. Fadi M. Kayali's office phone number?

The practice phone on file for Dr. Kayali is (941) 917-9000.

What is Dr. Fadi M. Kayali's medical license number?

Dr. Kayali holds Florida license ME106289, one of the licenses on file in 4 states.

Which states has Dr. Fadi M. Kayali been licensed in?

Dmand AI has state licenses on file for Dr. Kayali in Florida (2010 to 2026), Oklahoma (2011 to 2012), Kentucky (2007 to 2011) and Michigan (2004 to 2007).

Which hospitals is Dr. Fadi M. Kayali affiliated with?

Dr. Kayali practices at Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida. Dr. Kayali is also affiliated with Sarasota Memorial Hospital-Venice. Dmand AI links Dr. Kayali to 2 more hospitals.

What medical group is Dr. Fadi M. Kayali part of?

Dr. Kayali is linked to Florida Cancer Specialists & Research Institute.

Does Dr. Fadi M. Kayali accept Medicare?

Yes. CMS data shows Dr. Kayali billed Medicare for 217,744 services in 2024, and Dr. Kayali accepts Medicare assignment.

Does Dr. Fadi M. Kayali offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kayali as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Fadi M. Kayali's MIPS score?

Dr. Kayali's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.

How many Medicare patients does Dr. Fadi M. Kayali see?

CMS counts 1,171 Medicare patients who saw Dr. Kayali in 2024, with an average age of 76.

Is Dr. Fadi M. Kayali board certified?

Yes. Dr. Kayali is board certified in hospice and palliative medicine by the American Board of Anesthesiology.

What services does Dr. Fadi M. Kayali bill to Medicare?

In 2024, Dr. Kayali's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J9144) and injected or infused drug (J9271).

Where did Dr. Fadi M. Kayali go to medical school?

Dr. Kayali graduated from St Petersburg Medical State Academy in 1997.

What drugs does Dr. Fadi M. Kayali prescribe most?

In 2024 Medicare Part D data, Dr. Kayali's most prescribed drugs by claims were Eliquis, Anastrozole and Gabapentin.

Has Dr. Fadi M. Kayali received payments from drug or device companies?

CMS Open Payments shows $33,196 in general payments to Dr. Kayali from 104 companies from 2016 to 2025. The largest total came from Genentech, Inc.

How long has Dr. Fadi M. Kayali been practicing?

Dr. Kayali graduated from medical school in 1997, 29 years ago.

Does Dr. Fadi M. Kayali do research?

Dmand AI links 21 publications to Dr. Kayali, published from 2005 to 2018. Dr. Kayali has worked on 10 clinical trials.

Who does Dr. Fadi M. Kayali publish with?

Dr. Kayali's most frequent co-authors are Issa G. Alesh, MD (3 shared papers), Majd Alnas, MD (2 shared papers) and Javier A. Pinilla-Ibarz, MD (2 shared papers).

What insurance does Dr. Fadi M. Kayali accept?

Dr. Kayali is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)